Artharal Tablet
Natural health product licensed in Canada
- Licence holder
- Bhargava Phytolab Pvt. Ltd.
- NPN or DIN-HM
- 80044807
- Status
- Active licence
- Licence date
- 18 September 2013
- Revision date
- 22 June 2021
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Homéopathique
If this product were sold in France
- Information
Homeopathic medicine in Canada, outside the scope of food supplements in France. Nutrient doses are not analysed.
Homéopathique. Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Ferrum phosphoricum Source : Phosphate de fer (III) | 3 X | Not calculated |
| Nux vomica Source : Graine(s) | 6 X | Not calculated |
| Lithium carbonicum Source : Carbonate de lithium | 6 C | Not calculated |
Non-medicinal ingredients
Lactose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 12 years | 1 Comprimé | 3 Tous les jours |
| Adultes | Not specified | 1 Comprimé | 3 Tous les jours |
| Enfants | minimum: 6 years ; maximum: 12 years | 0.5 Comprimé | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Homeopathic Remedy.
Homeopathic remedy to temporarily help relieve symptoms associated to joint pain in rheumatism such as minor swelling and stiffness, as well as minor pain in tendons and ligaments.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80044807
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging